Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Inflammation × Neoadjuvant Therapy × Clear all

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 85 Rectal Neoplasms 43 Colorectal Neoplasms 43 Carcinoma, Non-Small-Cell Lung 29 Esophageal Neoplasms 23 Esophageal Squamous Cell Carcinoma 21 Lung Neoplasms 20 Stomach Neoplasms 18 Pancreatic Neoplasms 18 Neoplasms 15 Colonic Neoplasms 14 Carcinoma, Hepatocellular 14 Neoplasm Metastasis 13 Squamous Cell Carcinoma of Head and Neck 12 Prostatic Neoplasms 12 Ovarian Neoplasms 12 Adenocarcinoma Of Esophagus 12 Head and Neck Neoplasms 11 Urinary Bladder Neoplasms 10 Sarcoma 10 Uterine Cervical Neoplasms 9 Osteosarcoma 8 Fallopian Tube Neoplasms 8 Inflammatory Breast Neoplasms 7 Central Nervous System Neoplasms 7 Carcinoma, Intraductal, Noninfiltrating 7 Multiple Myeloma 6 Liver Neoplasms 6 Kidney Neoplasms 6 Carcinoma, Ovarian Epithelial 6

Interventions

Exercise 5 Omeprazole 3 Etanercept 3 salicylsalicylic acid 2 palbociclib 2 XENP 1595 2 Vitamin D 2 Tea 2 Tablets 2 Surgical Procedures, Operative 2 Sufentanil 2 Spironolactone 2 Resistance Training 2 Pioglitazone 2 Oxycodone 2 Nutrition Assessment 2 Metformin 2 Ketorolac 2 Ibuprofen 2 Fish Oils 2 Dexmedetomidine 2 Colchicine 2 Blood Specimen Collection 2 Aspirin 2 Ascorbic Acid 2 ziprasidone 1 soybean oil, phospholipid emulsion 1 semaglutide 1 montelukast 1 microcrystalline cellulose 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06447532 2025-03-12

INFLAMMATE

Federal University of São Paulo

Enrolling by invitation

Breast Neoplasms, Inflammation

Data powered by HemOnc (CC BY 4.0) Colophon ⚡